Comparison of Osteoporosis Disease Management Strategies (0000-039)

Osteoporosis Clinical Trial

Official title:

Evaluation of Strategies for Increasing Osteoporosis Screening and Treatment in a Managed Care Organization

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00145080
• Other study ID #: 0000-039
• Secondary ID: 0392005_050
• Status: Completed
• Phase: N/A
• First received: September 1, 2005
• Last updated: October 30, 2015
• Start date: July 2004
• Est. completion date: January 2006

Study information

• Verified date: October 2015
• Source: Merck Sharp & Dohme Corp.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to assess the impact of disease management interventions on bone mineral density screening rates and osteoporosis treatment rates in women age 50-64 years at high risk for osteoporosis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 4685
• Est. completion date: January 2006
• Est. primary completion date: January 2006
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 50 Years to 64 Years

Eligibility

Inclusion Criteria:

• Members of the Harvard Pilgrim Health Plan

Exclusion Criteria:

• Individuals who are not members of the Harvard Pilgrim Health Plan

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Osteoporosis

Intervention

Behavioral:
• Disease Management Assessment

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Merck Sharp & Dohme Corp.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Bone mineral density screening rates
Secondary	Medications adoptions; Medications adherence